Pharmacokinetics properties of surface-modified vesicles

Keitaro Sou, Beth Coins, William T. Phillips, Shinji Takeoka, Eishun Tsuchida

Resultado de la investigación: Paperrevisión exhaustiva


Phospholipid vesicles, also called liposome, are potent carriers of various drugs and offer a drug targeting system into specific organs, tissues, or cells, to minimize the drug administration dose and improve the therapeutic safety. Recently, we have found that phospholipid vesicle containing an anionic amphiphile; 1,5-dihexadecyl-L-glutamate-N-succinic acid (Suc-2C 16) and polyethylene glycol)-lipid (PEG-DSPE) are mainly up taken by rabbit bone marrow at a small injection dose (15 mg/kg b.w.). At 24 h after intravenous injection of 99m-technetimu ( 99mTc)-labeled vesicles in rabbit, biodistribution data clearly indicated that the component of Suc-2C 16 induced the significant affinity to bone marrow in comparison with control vesicles, which do not have Suc-2C 16. Further incorporation of as little as 0.6 mol% of PEG-DSPE passively enhanced the distribution of Suc-Ve into bone marrow inhibiting the liver uptake, and this formulation was distributed in the bone marrow over the whole body, reaching to 70% of the injected dose by 6 h after injection.

Idioma originalEnglish (US)
Número de páginas2
EstadoPublished - dic 1 2005
Evento54th SPSJ Symposium on Macromolecules - Yamagata, Japan
Duración: sept 20 2005sept 22 2005


Other54th SPSJ Symposium on Macromolecules

ASJC Scopus subject areas

  • Engineering(all)


Profundice en los temas de investigación de 'Pharmacokinetics properties of surface-modified vesicles'. En conjunto forman una huella única.

Citar esto